Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Nuvation Bio Inc. Class A Common Stock
(NY:
NUVB
)
6.265
-0.065 (-1.03%)
Streaming Delayed Price
Updated: 1:49 PM EDT, Aug 3, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,745,902
Open
6.360
Bid (Size)
6.260 (3,100)
Ask (Size)
6.270 (1,400)
Prev. Close
6.330
Today's Range
6.075 - 6.420
52wk Range
2.180 - 9.750
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Nuvation Bio Stock Is Up 190% Despite Recent Pressure. Should Investors Care About This $753,000 Insider Sale?
↗
June 29, 2026
This oncology biotech advancing targeted therapies reported a notable insider sale amid ongoing clinical-stage development.
Via
The Motley Fool
Topics
Regulatory Compliance
Veteran Pharma VC Insider Buys 25,000 Nuvation Bio Shares as New Drug Gains Momentum
↗
June 17, 2026
Clinical-stage biotech Nuvation Bio, focused on oncology therapeutics, reported a recent insider buy amid a year of sharp share price gains.
Via
The Motley Fool
Topics
Regulatory Compliance
Performance
YTD
-27.0%
-27.0%
1 Month
+11.9%
+11.9%
3 Month
+42.1%
+42.1%
6 Month
+11.3%
+11.3%
1 Year
+171.2%
+171.2%
More News
Read More
Bicara Stock Is Up 50%, and One Biotech Investor Has Made It a 29% Portfolio Bet
↗
May 15, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Nuvation Bio (NYSE:NUVB) Soars 22% After Earnings Beat Fueled by Strong Lung Cancer Drug Launch
↗
May 04, 2026
Via
Chartmill
Topics
Earnings
NUVATION BIO INC (NYSE:NUVB) Stock Plunges 9% After Q4 Earnings Reveal Revenue Beat but Wider Loss
↗
March 02, 2026
Via
Chartmill
Nuvation Bio Stock Logs Its Best Session Ever: Wall Street Turns Bullish On Lung Cancer Drug’s Blockbuster Debut
↗
November 20, 2025
Via
Stocktwits
Alumis Stock Is Up Over 300%. One Major Healthcare Investor Is Cutting Back
↗
May 15, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares
↗
May 15, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Nuvation Bio (NUVB) Q1 2026 Earnings Transcript
↗
May 04, 2026
Via
The Motley Fool
Insider Sells 200K Shares of Biotech Company Nuvation Bio (NUVB)
↗
April 13, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB
March 24, 2026
From
Pomerantz LLP
Via
GlobeNewswire
NUVB Investors Have Opportunity to Join Nuvation Bio Inc. Fraud Investigation with the Schall Law Firm
March 21, 2026
From
The Schall Law Firm
Via
Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB
March 17, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB
March 10, 2026
From
Pomerantz LLP
Via
GlobeNewswire
SSR Mining Stock Up 180% as New $5 Million Stake Signals Gold Conviction
↗
March 03, 2026
Via
The Motley Fool
Topics
ETFs
Regulatory Compliance
Nuvation Bio Stock Up 130% This Past Year as One Fund Discloses $3 Million Buy
↗
March 03, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Which stocks are gapping on Tuesday?
↗
March 03, 2026
Via
Chartmill
Nuvation Bio (NUVB) Q4 2025 Earnings Transcript
↗
March 03, 2026
Via
The Motley Fool
Nuvation Bio Announces Pivotal Global Phase 3 SIGMA Trial (G203) for Safusidenib in IDH1-Mutant Glioma
February 09, 2026
From
Nuvation Bio
Via
Business Wire
Nuvation Bio Reports Preliminary Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook Ahead of 44th Annual J.P. Morgan Healthcare Conference
January 12, 2026
From
Nuvation Bio
Via
Business Wire
Nuvation Bio and Eisai Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside U.S., China and Japan
January 12, 2026
From
Nuvation Bio and Eisai
Via
Business Wire
Nuvation Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 06, 2026
From
Nuvation Bio
Via
Business Wire
Nuvation Bio Announces Publication of Positive Phase 2 Study Results for Safusidenib for the Treatment of Grade 2 IDH1-Mutant Glioma in Neuro-Oncology
December 03, 2025
From
Nuvation Bio
Via
Business Wire
Nuvation Bio to Participate in Upcoming Investor Conferences
November 26, 2025
From
Nuvation Bio
Via
Business Wire
Nuvation Bio (NUVB) Soars on IBTROZI's Blockbuster Launch and Stellar Q3 2025 Performance
November 19, 2025
Via
MarketMinute
Frequently Asked Questions
Is Nuvation Bio Inc. Class A Common Stock publicly traded?
Yes, Nuvation Bio Inc. Class A Common Stock is publicly traded.
What exchange does Nuvation Bio Inc. Class A Common Stock trade on?
Nuvation Bio Inc. Class A Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Nuvation Bio Inc. Class A Common Stock?
The ticker symbol for Nuvation Bio Inc. Class A Common Stock is NUVB on the New York Stock Exchange
What is the current price of Nuvation Bio Inc. Class A Common Stock?
The current price of Nuvation Bio Inc. Class A Common Stock is 6.265
When was Nuvation Bio Inc. Class A Common Stock last traded?
The last trade of Nuvation Bio Inc. Class A Common Stock was at 08/03/26 01:49 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
